Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 3A (CYP3A) refers to a subfamily within the cytochrome P450 superfamily of enzymes. These are heme-thiolate monooxygenases that play a central role in the oxidative metabolism of both endogenous and exogenous compounds, including drugs, hormones, toxins, and carcinogens. The CYP3A subfamily is the most abundant group of CYP enzymes in human liver and intestine. CYP3A4 is the most prevalent and clinically significant isoform in adults. They are highly expressed in the liver and small intestine. CYP3A enzymes catalyze monooxygenation reactions using NADPH as an electron donor. Because they metabolize so many pharmaceuticals, drug-drug interactions involving inhibition or induction of CYP3As are common clinical concerns.
Oxidative metabolism of drugs and endogenous compounds, leading to their inactivation or activation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 3A (CYP3A).